Delivery Order SPE2DB22D3501-SPE2DB25FWH08
Award Date 7/7/25
Potential Completion Date 7/8/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ACTEMRA 200 MG/10 ML VIAL 10ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,471.52 and a period of performance through May 21, 2025. This award is not associated with a set-aside program and represents an open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA 200 MG/10 ML VIAL 10ML, a medical supply item, with a ceiling value of $3,295.36. It is a firm fixed-price delivery order contract with a period of performance ending on July 11, 2025. The contract is not set-aside and was awarded on July 10, 2025. Amerisourcebergen Drug Corp is...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,303.88, is for the delivery of ACTEMRA 80 MG/4 ML VIAL 4ML, a pharmaceutical product, under a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $30,179.46. The contract is a firm fixed price delivery order with a period of performance through February 19, 2025. This award is part of a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,946.84, is a Delivery Order for the ACTEMRA 400 MG/20 ML VIAL 20ML pharmaceutical product. The contract has an ultimate completion date of November 4, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $2,471.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ACTEMRA 200 MG/10 ML VIAL 10ML, a medical product, with a completion date of January 30, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,571.72 firm fixed price delivery order contract, awarded on October 16, 2024, is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,731.80, is a delivery order to supply the medication ACTEMRA 400 MG/20 ML VIAL 20ML. The contract has a firm fixed price and an ultimate completion date of March 20, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,754.13, is a delivery order for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a biologic medication used to treat certain autoimmune conditions. The contract has an ultimate completion date of November 7, 2024 and is a firm fixed price arrangement. This contract award is not associated with any...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,471.52, is for the delivery of ACTEMRA 200 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...